A dopa decarboxylase inhibitor (DDCI), such as carbidopa or benserazide, is administered with levodopa to attenuate its peripheral conversion to dopamine, reduce nausea and increase central ...

Combining levodopa with a DDC inhibitor (DDCI), such as carbidopa or benserazide, greatly reduces the incidence of nausea and vomiting, increases the levodopa half-life from approximately 60 to 90 ...

Selective MAO-B inhibitors work by preventing the breakdown of dopamine to increase its activity. They are usually prescribed ...

Its design means that therapeutic levels of levodopa and carbidopa may be maintained ... be used with nonselective monoamine oxidase (MAO) inhibitors. It also warns that the drug should not ...